GDF15 and cancer: Unfortunately, study of GDF15 in paediatric oncology is mostly limited to the long‐term cardiotoxicity in childhood cancer survivors who received anthracycline therapy without dedicated disease‐specific study of GDF15's role in development, progression, or treatment resistance.